Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Letters to the Editor

Vitamin D and Cancer Incidence—Response to Grant

Tea Skaaby, Lise Lotte Nystrup Husemoen and Allan Linneberg
Tea Skaaby
Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tea.skaaby.01@regionh.dk
Lise Lotte Nystrup Husemoen
Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Linneberg
Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark.Department of Clinical Experimental Research, Glostrup University Hospital, Glostrup, Denmark.Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-14-0670 Published September 2014
  • Article
  • Info & Metrics
  • PDF
Loading

We thank Grant (1) for his thoughtful reading and commenting of our article (2). First, Grant mentions that the long follow-up time in the study may be the reason for not finding statistically significant associations between vitamin D and cancer risk. In additional analyses not included in our article, we therefore included a maximum of 5 years of follow-up only (5.0 year median follow-up time). Hazard ratios [HR; number of events (n)/total number (N); 95% confidence intervals (CI)] per 10 nmol/L higher baseline vitamin D level were now (only categories with >20 events are shown): for all cancers (n = 371/N = 10,709; HR, 1.03; 95% CI, 0.98–1.07), all cancers excluding non-melanoma skin cancer (NMSC; n = 297/N = 10,866; HR, 1.01; 95% CI, 0.96–1.06), colorectal cancer (n = 43/N = 11,119; HR, 0.94; 95% CI, 0.82–1.08), cancer of bronchus and lung (n = 32/N = 11,133; HR, 1.04; 95% CI, 0.91–1.19), breast cancer (n = 72/N = 5,606; HR, 1.02; 95% CI, 0.93–1.12), prostate cancer (n = 29/N = 5,451; HR, 1.03; 95% CI, 0.88–1.21), NMSC (n = 98/N = 10,972; HR, 1.09; 95% CI, 1.01–1.18), and malignant melanoma (n = 22/N = 11,100; HR, 1.00; 95% CI, 0.84–1.19). Thus, consistent with our published results, our data do not support the hypothesis that there is a beneficial effect of a higher vitamin D status on cancer risk when using shorter follow-up time.

Another concern raised is the different levels of vitamin D in the three studies. To take this into account, we performed meta-analyses of the study-specific estimates (2, 3). Despite signs of heterogeneity across the cohorts, the estimates were quite similar to the results from the pooled data analyses. In addition, the limitation of the assumption of a linear association between vitamin D and risk of cancer is mentioned. In fact, we analyzed the data both with vitamin D status in season-specific quartiles and as a continuous variable where we found the quadratic term of vitamin D status nonsignificant in all models (2). In this way, there were no signs of nonlinear relationships between vitamin D status and cancer risk.

See the original Letter to the Editor, p. 1950

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

  • Received June 11, 2014.
  • Accepted June 11, 2014.
  • ©2014 American Association for Cancer Research.

References

  1. 1.↵
    1. Grant WB
    . Vitamin D and cancer incidence—letter from Grant. Cancer Epidemiol Biomarkers Prev 2014;23:1950.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Skaaby T,
    2. Husemoen LL,
    3. Thuesen BH,
    4. Pisinger C,
    5. Jorgensen T,
    6. Roswall N,
    7. et al.
    Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev 2014;23:1220–9.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Riley RD,
    2. Lambert PC,
    3. Abo-Zaid G
    . Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221.
    OpenUrlFREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (9)
September 2014
Volume 23, Issue 9
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Vitamin D and Cancer Incidence—Response to Grant
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
Vitamin D and Cancer Incidence—Response to Grant
Tea Skaaby, Lise Lotte Nystrup Husemoen and Allan Linneberg
Cancer Epidemiol Biomarkers Prev September 1 2014 (23) (9) 1951; DOI: 10.1158/1055-9965.EPI-14-0670

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Vitamin D and Cancer Incidence—Response to Grant
Tea Skaaby, Lise Lotte Nystrup Husemoen and Allan Linneberg
Cancer Epidemiol Biomarkers Prev September 1 2014 (23) (9) 1951; DOI: 10.1158/1055-9965.EPI-14-0670
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Shift Work, Chronotype, and Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Letter
  • Night Shift Work Increases Cancer Risk of Women—Letter
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement